High Court Preemption Ruling Would Hit Branded Cos. Hard
If the U.S. Supreme Court finds that generic-drug makers are not liable for state failure-to-warn claims in a case alleging that federal regulations shield generics makers from such allegations, lawsuits against...To view the full article, register now.
Already a subscriber? Click here to view full article